{
    "title": "Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8869929/Gileads-remdesivir-gets-U-S-FDA-approval.html",
    "date": "2020-10-22",
    "keywords": [
        "remdesivir",
        "drug",
        "gilead",
        "covid19",
        "approval",
        "beasley",
        "emergency",
        "use",
        "authorization",
        "study",
        "health",
        "hospital",
        "potential",
        "veklury",
        "fda",
        "demand",
        "company",
        "food",
        "administration",
        "disease",
        "president",
        "bout",
        "fdas",
        "debate",
        "joe",
        "biden",
        "election",
        "eua",
        "institutes",
        "world",
        "organization",
        "week",
        "trial",
        "effect",
        "length",
        "stay",
        "survival",
        "bias",
        "meaning",
        "brand",
        "name",
        "treatment",
        "course",
        "government",
        "department",
        "standard",
        "care",
        "moderatelyill",
        "illness",
        "doesnt",
        "change",
        "outlook",
        "standardofcare",
        "raymond",
        "analyst",
        "seedhouse",
        "research",
        "note",
        "prescribing",
        "case",
        "end",
        "age",
        "part",
        "combination",
        "therapy",
        "version",
        "reporting",
        "chander",
        "bengaluru",
        "deena",
        "osterman",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}